WSJ -- Johnson & Johnson sold its St. Joseph’s aspirin brand to a closely held Baltimore company for an undisclosed sum, the companies said Thursday.
WSJ -- Johnson & Johnson sold its St. Joseph’s aspirin brand to a closely held Baltimore company for an undisclosed sum, the companies said Thursday.